Cobas EGFR Mutation Test v2 gets expanded approval

Create PDF

The Cobas EGFR Mutation Test v2 is an RT-PCR test for the qualitative detection of defined mutations of the epidermal growth factor receptor gene in NSCLC patients. Defined EGFR mutations are detected using DNA isolated from formalin-fixed, paraffin-embedded tumor tissue or circulating tumor DNA from plasma derived from EDTA anticoagulated peripheral whole blood. Results are available in less than eight hours.